The paradigm for a product-development or research plan presents a seemingly straightforward progression: You discover a new gene or protein, and you develop one or more end products that you can market. 

Most people involved with research, however, know that this is not how the real world works. This paradigm, for example, fails to reflect the various setbacks and unworkable avenues that exist throughout development.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.